(Global Executive Moves is a news service brought to you by Kingsley Gate Partners. This should not to be construed as placements made by KGP.)
Life Science Industry Banner - Advancing Healthcare Solutions
Mouse Scroll Icon
June 2021

Personal Genome Diagnostics Appoints Brent Dial as Chief Financial Officer

Personal Genome Diagnostics appointed Brent Dial as Chief Financial Officer. He joins with 19 years of experience, most recently being Principal at Chordata Ventures, where he provided corporate finance advisory services and spent time as interim CFO for several portfolio companies.

Personal Genome Diagnostics (PGDx) is empowering the fight against cancer by unlocking actionable information from the genome. It is based in Baltimore, MD.